Sweden will not recommend the Oxford AstraZeneca vaccine to over-65s, the country’s health ministry said on February 2, 2021.
It comes after Germany advised against administering the jab to those over 65 and Emmanuel Macron claimed it was ‘almost ineffective’ for the age bracket.
It is not clear why Stockholm objects to the vaccine but the Germans said there was a lack of data to show how the vaccine affected elderly patients.
Boris Johnson and UK health chiefs have insisted that the jab, made by Swedish-British pharmaceutical giant AstraZeneca, is effective for all age groups.
The Prime Minister said the jab ‘is very good and efficacious’ after health officials in Berlin warned that there was ‘insufficient data to assess the efficacy of the vaccine for persons aged 65 years and older.’
AstraZeneca has been open in saying that in their initial tests only 10 percent of the participants were 65 or older.
But, there are trials ongoing throughout the world to test its efficacy for those over 65 and the vaccine is central to Britain’s Europe-beating roll-out operation.
This is a breaking story and will be updated.